Clinical Trials in Arizona

Showing 5261-5280 of 12,706 trials

ALT-801 in Diabetic and Non-Diabetic Overweight and Obese Subjects With Non-alcoholic Fatty Liver Disease (NAFLD)

NCT05006885

The purpose of the study is to assess the safety and tolerability of ALT-801 in diabetic and non-diabetic subjects with overweight and obese and non-alcoholic fatty liver disease (NAFLD).

Non-Alcoholic Fatty Liver Disease

Altimmune, Inc.95 participantsStarted Sep 2021

Scottsdale, Arizona, United States • Tucson, Arizona, United States • Montclair, California, United States +12 more locations

COMPLETEDNA31 miles

Comprehensive Genetic Assessment, Risk and Education in a Mammography Pilot

NCT04002986

Researchers are trying to learn more about the prevalence of genetic mutations in women who are at intermediate/high risk of breast cancer and how that information my assist providers in improving screening and preventative options.

Women Age 35+ Qualifies if >15% Lifetime Risk of Breast Cancer as Defined by IBIS Version 8

Mayo Clinic116 participantsStarted Aug 2019

Scottsdale, Arizona, United States

ALT-801 in Diabetic and Non-Diabetic Overweight and Obese Subjects With Non-alcoholic Fatty Liver Disease (NAFLD)

Comprehensive Genetic Assessment, Risk and Education in a Mammography Pilot

Find Trials by Condition in Arizona

Pro-Active Genetic Testing in Patients With Solid Tumors, Inherit Study

A Study to Investigate the Safety and Efficacy of Elsubrutinib and Upadacitinib Given Alone or in Combination in Participants With Moderately to Severely Active Systemic Lupus Erythematosus (SLE)

Study of Iomab-B vs. Conventional Care in Older Subjects With Active, Relapsed or Refractory Acute Myeloid Leukemia

A Trial of Tisotumab Vedotin in Cervical Cancer

Vicinium Treatment for Subjects With Non-muscle Invasive Bladder Cancer Previously Treated With BCG

Left Atrial Pressure Monitoring to Optimize Heart Failure Therapy

A Phase III Safety Study of Ferumoxytol Compared to Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia (IDA)

A Study of CIN-107 in Adults With Treatment-Resistant Hypertension (rHTN)

Study to Investigate the Safety of a Drug Called Osocimab at Low and High Doses in Adult Patients With Kidney Failure Requiring Regular Hemodialysis

Real-World Evidence of Duration of Effect of Adhansia XR (Extended-Release) for Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD)

Safety, PK and Efficacy of PCS12852 on Gastric Emptying Rate in Patients With Moderate to Severe Gastroparesis

A Study of INCMGA00012 in Participants With Selected Solid Tumors (POD1UM-203)

Pharmacokinetics (PK), Safety, Efficacy and Maximal Use PK of ARQ-151 in Adolescents/Children With Mild/Moderate Eczema

Lintuzumab-Ac225 in Older Acute Myeloid Leukemia (AML) Patients

Safety and Efficacy Study of the Neurent Medical NEUROMARK™ System in Subjects With Chronic Rhinitis

Study of MK-8353 + Selumetinib in Advanced/Metastatic Solid Tumors (MK-8353-014)

Palliative Care Interventions for Outpatients Newly Diagnosed With Lung Cancer: Phase II

Mifepristone and Two Doses of Misoprostol for Abortion at 11&12 Weeks